Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapies.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 19005278)

Published in AIDS on November 30, 2008

Authors

Gilles J Thöni1, Iris Schuster, Guillaume Walther, Stéphane Nottin, Agnès Vinet, Franck Boccara, Jean-Marc Mauboussin, Isabelle Rouanet, Stéphane Edérhy, Michel Dauzat, Patick Messner-Pellenc, Philippe Obert

Author Affiliations

1: EA 4278, Faculty of Sciences, Avignon, France. gilles.thoni@univ-montp1.fr

Associated clinical trials:

Register of Cardiovascular Complications Among People Living With HIV (RECOVIH) | NCT02453919

Articles by these authors

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4. Arch Intern Med (2010) 2.17

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr (2004) 2.12

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood (2004) 1.97

Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS (2010) 1.93

Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78

Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging. Am J Cardiol (2006) 1.62

Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol (2008) 1.59

Vascular smooth muscle function in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia (2013) 1.56

Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood (2011) 1.53

Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes (2006) 1.49

Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Am J Kidney Dis (2008) 1.44

Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet (2002) 1.44

β-Adrenergic receptors desensitization is not involved in exercise-induced cardiac fatigue: NADPH oxidase-induced oxidative stress as a new trigger. J Appl Physiol (1985) (2011) 1.39

Wall mechanics of the stented extracranial carotid artery. Stroke (2003) 1.38

HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis (2012) 1.28

Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res (2007) 1.22

Kinetics of left ventricular strains and torsion during incremental exercise in healthy subjects: the key role of torsional mechanics for systolic-diastolic coupling. Circ Cardiovasc Imaging (2010) 1.19

HIV-associated lipodystrophy: from fat injury to premature aging. Trends Mol Med (2010) 1.10

Sports-specific features of athlete's heart and their relation to echocardiographic parameters. Herz (2006) 1.09

Enhanced conduit artery flow-mediated dilation in elite athletes: false or reality? [corrected]. Med Sci Sports Exerc (2013) 1.08

Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy. AIDS (2013) 1.07

Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis. J Acquir Immune Defic Syndr (2008) 1.06

Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study. J Electrocardiol (2010) 1.06

FKBP12.6 overexpression decreases Ca2+ spark amplitude but enhances [Ca2+]i transient in rat cardiac myocytes. Am J Physiol Heart Circ Physiol (2004) 1.01

Doppler echocardiography for the estimation of cardiac output with exercise. Sports Med (2002) 0.99

Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system. Arterioscler Thromb Vasc Biol (2013) 0.98

Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study. Br J Clin Pharmacol (2008) 0.97

Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin. Arterioscler Thromb Vasc Biol (2010) 0.96

Different modalities of exercise to reduce visceral fat mass and cardiovascular risk in metabolic syndrome: the RESOLVE randomized trial. Int J Cardiol (2013) 0.94

Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial. AIDS (2010) 0.93

Abacavir and cardiovascular risk: reviewing the evidence. Curr HIV/AIDS Rep (2010) 0.91

Streamlined flow in the portal vein: demonstration with MR angiography. J Magn Reson Imaging (2002) 0.91

Hemodynamic and cardiac electrophysiologic effects of lidocaine-bupivacaine mixture in anesthetized and ventilated piglets. Anesthesiology (2003) 0.91

Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli. Mol Cell Endocrinol (2010) 0.90

Carbon monoxide pollution promotes cardiac remodeling and ventricular arrhythmia in healthy rats. Am J Respir Crit Care Med (2009) 0.90

Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial. Thromb Haemost (2010) 0.88

The association between hereditary thrombophilias and pregnancy loss. Haematologica (2005) 0.88

Diastolic dysfunction and intraventricular dyssynchrony are restored by low intensity exercise training in obese men. Obesity (Silver Spring) (2011) 0.87

Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial. Thromb Haemost (2011) 0.87

Exercise response in hypertrophic cardiomyopathy: blunted left ventricular deformational and twisting reserve with altered systolic-diastolic coupling. Circ Cardiovasc Imaging (2012) 0.86

Cardiac function during exercise in obese prepubertal boys: effect of degree of obesity. Obesity (Silver Spring) (2009) 0.86

In vitro and in vivo study of human amniotic fluid-derived stem cell differentiation into myogenic lineage. Clin Exp Med (2010) 0.85

Myocardial deformation and twist mechanics in adults with metabolic syndrome: impact of cumulative metabolic burden. Obesity (Silver Spring) (2013) 0.85

Training does not affect the alteration in pulmonary artery vasoreactivity in pulmonary hypertensive rats. Eur J Pharmacol (2005) 0.84

Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologists. Crit Rev Oncol Hematol (2011) 0.84

Effects of exercise training on arterial function in type 2 diabetes mellitus: a systematic review and meta-analysis. Sports Med (2013) 0.84

Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation. Am J Cardiol (2007) 0.83

Two-dimensional strain and twist by vector velocity imaging in adolescents with severe obesity. Obesity (Silver Spring) (2012) 0.83

Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine. AIDS (2015) 0.83

Left ventricular function in endurance-trained children by tissue Doppler imaging. Med Sci Sports Exerc (2004) 0.83

Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. Arch Cardiovasc Dis (2010) 0.83

Carbon monoxide exposure enhances arrhythmia after cardiac stress: involvement of oxidative stress. Basic Res Cardiol (2011) 0.83

Influence of body composition, hemoglobin concentration, and cardiac size and function of gender differences in maximal oxygen uptake in prepubertal children. Chest (2003) 0.83

Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers. AIDS (2016) 0.83

Prevalence and occurrence of stress urinary incontinence in elite women athletes. Can J Urol (2006) 0.82

Flow-mediated dilation in athletes: influence of aging. Med Sci Sports Exerc (2014) 0.82

Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Curr Pharm Des (2014) 0.82

Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood (2003) 0.82

Time course of asymptomatic interstitial pulmonary oedema at high altitude. Respir Physiol Neurobiol (2012) 0.82

Impact of a lifestyle program on vascular insulin resistance in metabolic syndrome subjects: the RESOLVE study. J Clin Endocrinol Metab (2014) 0.81

Specific left ventricular twist-untwist mechanics during exercise in children. J Am Soc Echocardiogr (2013) 0.81

QT interval prolongation among patients treated with angiogenesis inhibitors. Target Oncol (2009) 0.81

C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation. Int J Cardiol (2011) 0.81

Prophylaxis and treatment of thrombophilia in pregnancy. Curr Opin Hematol (2006) 0.81

Alteration in left ventricular strains and torsional mechanics after ultralong duration exercise in athletes. Circ Cardiovasc Imaging (2009) 0.81

Central and peripheral cardiovascular adaptations during a maximal cycle exercise in boys and men. Med Sci Sports Exerc (2002) 0.81

(.)VO(2) and EMG activity kinetics during moderate and severe constant work rate exercise in trained cyclists. Can J Appl Physiol (2004) 0.80